Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY2R | P49146 | 7/20 | 0.54 |
| ▸ | NPY4R | P50391 | 7/20 | 0.54 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.54 |
| ▸ | NPY1R | P25929 | 6/20 | 0.54 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.53 |
| ▸ | NMUR2 | Q9GZQ4 | 3/20 | 0.52 |
| ▸ | NMUR1 | Q9HB89 | 2/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.52 |
| ▸ | CXCL8 | P10145 | 5/20 | 0.51 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30690383 | 0.89 | OPRM1 (0.56) | NPY1ROPRM1OPRD1 | |
| SCHEMBL30343609 | 0.88 | OPRM1 (0.56) | NMUR2NMUR1OPRM1OPRD1 | |
| SCHEMBL31332000 | 0.87 | NMUR2 (0.61) | NPY2RNPY4RNPY5RNPY1RNMUR2 | |
| SCHEMBL31114351 | 0.87 | SLC6A2 (0.54) | OPRM1OPRD1 | |
| SCHEMBL29746989 | 0.86 | SLC6A2 (0.54) | EPHA2NMUR2OPRM1 | |
| SCHEMBL29796546 | 0.85 | OPRM1 (0.56) | NMUR2NMUR1OPRM1OPRD1 | |
| SCHEMBL29592580 | 0.85 | SLC6A2 (0.60) | OPRM1OPRD1 | |
| SCHEMBL30930552 | 0.84 | NPY2R (0.60) | NPY2RNPY4RNPY5RNPY1ROPRM1 | |
| SCHEMBL30586993 | 0.84 | NTSR2 (0.57) | NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL31490020 | 0.83 | OPRM1 (0.59) | NMUR2NMUR1OPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112029766-B | Application of double-stranded RNA | 江苏仁明生物科技有限公司 | 2024-06-18 | — | — | CN | disclosed |